Proteomes

Scope & Guideline

Unlocking the Secrets of Protein Structures and Functions.

Introduction

Explore the comprehensive scope of Proteomes through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Proteomes in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherMDPI
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationPROTEOMES / Proteomes
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND

Aims and Scopes

The journal 'Proteomes' focuses on the field of proteomics, emphasizing the analysis of protein structures, functions, and interactions in various biological contexts. It aims to bridge fundamental research with clinical applications, highlighting the significance of proteomics in understanding diseases and developing therapeutic strategies.
  1. Proteomic Analysis of Biological Samples:
    The journal publishes studies that utilize proteomic techniques to analyze various biological samples, including tissues, fluids, and cells, to uncover insights into biological processes and disease mechanisms.
  2. Integration of Multi-Omics Approaches:
    A consistent focus on the integration of proteomics with other omics disciplines such as genomics and metabolomics, allowing for a more comprehensive understanding of biological systems and disease states.
  3. Clinical Applications of Proteomics:
    Research that translates proteomic findings into clinical applications, particularly in the identification of biomarkers for disease diagnosis, prognosis, and treatment, is a core area of interest.
  4. Technological Advancements in Proteomics:
    The journal highlights innovative methodologies and technological advancements in proteomics, including mass spectrometry, bioinformatics, and sample preparation techniques, which enhance the capabilities of proteomic studies.
  5. Proteomics in Environmental and Agricultural Studies:
    The journal also explores the application of proteomics in environmental science and agriculture, focusing on plant and microbial proteomics to address challenges in food security and sustainability.
Recent publications in 'Proteomes' indicate a shift towards several emerging themes that reflect the current trends in the field of proteomics. These themes highlight the evolving nature of research and its relevance to contemporary scientific challenges.
  1. Cancer Proteomics and Personalized Medicine:
    A significant increase in studies focusing on cancer proteomics, particularly in relation to personalized medicine and the identification of specific biomarkers for various cancer types, shows the journal's commitment to addressing cancer-related challenges.
  2. Integration of Proteomics with Artificial Intelligence and Machine Learning:
    Emerging research that applies AI and machine learning techniques to proteomics data analysis demonstrates a growing trend towards computational approaches, enhancing data interpretation and biomarker discovery.
  3. Proteomics in Neurodegenerative Disease Research:
    An increased focus on the role of proteomics in understanding neurodegenerative diseases, including Alzheimer's and Parkinson's, highlights the journal's alignment with pressing health issues and the quest for effective therapeutic strategies.
  4. Environmental and Ecological Proteomics:
    There is an emerging interest in the application of proteomics in environmental and ecological studies, addressing issues such as climate change, plant stress responses, and microbial interactions, reflecting a broader understanding of biological impacts on ecosystems.
  5. Post-Translational Modifications (PTMs) Research:
    Research on post-translational modifications, particularly in relation to their functional implications in diseases and cellular processes, is gaining traction, indicating a trend towards understanding the complexity of protein regulation.

Declining or Waning

While 'Proteomes' has expanded its focus on various emerging themes, certain areas of research have shown a decline in prominence over recent years. The following scopes have been observed to receive less attention in recent publications.
  1. Basic Proteomics Methodologies:
    There has been a noticeable decrease in publications solely focused on basic proteomics methodologies without an application context, as the field has shifted towards more integrative and applied studies.
  2. Single-Organism Proteomics Studies:
    Research focusing exclusively on the proteomics of single organisms, especially non-human models, has diminished, with a greater emphasis now on comparative and integrative studies across species.
  3. Classical Biomarker Studies:
    Traditional approaches to biomarker discovery that rely heavily on single-protein analysis have waned, giving way to more complex multi-omics strategies that consider the interplay of multiple biological molecules.
  4. Proteomics in Non-Clinical Settings:
    The application of proteomics in non-clinical settings, such as basic research without direct implications for health or disease, has seen a decline as the journal moves towards a more clinically relevant narrative.

Similar Journals

Journal of Proteomics

Advancing the frontiers of protein science.
Publisher: ELSEVIERISSN: 1874-3919Frequency: 18 issues/year

Journal of Proteomics, published by Elsevier, is an esteemed peer-reviewed journal dedicated to advancing research in the field of proteomics, with broad implications for biochemistry and biophysics. Established in 2008, the journal has continuously evolved, embracing innovative methodologies and technologies that facilitate protein analysis from a variety of biological systems. With its current standing in the Q2 category for both biochemistry and biophysics as of 2023, it is recognized as a significant contributor to scientific literature. The journal publishes original research articles, reviews, and methodological advancements, providing invaluable insights for researchers, professionals, and students alike. Although it does not offer open access, the journal remains a crucial platform for disseminating knowledge that informs various applications, ranging from drug development to disease understanding. As it converges towards 2024, the Journal of Proteomics continues to solidify its role in shaping the future of proteomic research through rigorous scientific inquiry and innovation.

PROTEIN AND PEPTIDE LETTERS

Exploring the forefront of biochemistry and structural biology.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 0929-8665Frequency: 12 issues/year

PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.

Bioinformatics Advances

Innovative Insights for Computational Biology
Publisher: OXFORD UNIV PRESSISSN: Frequency: 1 issue/year

Bioinformatics Advances, published by Oxford University Press, is an esteemed academic journal that serves as a vital platform for the dissemination of innovative research in the rapidly evolving fields of bioinformatics and computational biology. With a promising E-ISSN of 2635-0041, this journal has made significant strides since its inception in 2021, achieving a commendable Q1 ranking in both the Computer Science Applications and Genetics categories, alongside respectable Q2 rankings in Molecular Biology and Structural Biology as of 2023. Though currently not an open-access publication, its critical insights cater to an audience keen on advancing knowledge and technology in genomic studies and data analytics. The journal emphasizes high-quality research and aims to facilitate the integration of computational techniques within biological sciences, making it an essential resource for researchers, professionals, and students alike who seek to stay at the forefront of bioinformatics advancements.

Clinical Proteomics

Unveiling the Power of Proteins in Health and Disease
Publisher: BMCISSN: 1542-6416Frequency: 1 issue/year

Clinical Proteomics is a leading open-access journal, published by BMC since 2011, that aims to advance the field of proteomics by providing a platform for the dissemination of original research, critical reviews, and technological advancements in the analysis of proteins and their roles in health and disease. With an ISSN of 1542-6416 and E-ISSN 1559-0275, this esteemed journal covers a broad scope, converging years of research from 2004 to 2024. As a distinguished publication, it holds a Q1 ranking in Clinical Biochemistry and Q2 in both Molecular Biology and Molecular Medicine, reflecting its significance in the scientific community. Clinical Proteomics' commitment to open access ensures that its content is readily available to researchers, professionals, and students worldwide, facilitating the exchange of knowledge and fostering collaborative efforts in proteomic studies. Situated in the United Kingdom, this journal plays a pivotal role in shaping the future of biomedical research, appealing to anyone keen on the integration of proteomics in clinical practice and molecular investigation.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Pioneering Research in Biochemistry and Biophysics
Publisher: ELSEVIERISSN: 1570-9639Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, published by Elsevier, is a prestigious academic journal that serves as a vital resource for researchers, professionals, and students in the fields of biochemistry, biophysics, and proteomics. With an ISSN of 1570-9639 and an E-ISSN of 1878-1454, this journal features high-impact research articles aimed at advancing our understanding of protein structure, function, and interactions, contributing significantly to both theoretical and applied sciences. Recognized for its quality, it proudly holds a Q1 ranking in Analytical Chemistry and Biophysics, and Q2 in Biochemistry for 2023, alongside notable Scopus rankings that reflect its influence in the realm of molecular biology. The journal's commitment to disseminating essential findings supports the ongoing evolution of proteomic sciences and encourages collaborative discourse among the global scientific community. For aspiring authors, the journal offers open access options, enabling broad visibility of their work. Join the conversation in this dynamic field and contribute to shaping the future of protein research!

Expert Review of Proteomics

Elevating Proteomic Research to New Heights.
Publisher: TAYLOR & FRANCIS LTDISSN: 1478-9450Frequency: 6 issues/year

Expert Review of Proteomics, published by TAYLOR & FRANCIS LTD, is a distinguished journal that focuses on the latest advancements in the field of proteomics, a critical area within biochemistry and molecular biology. With an ISSN of 1478-9450 and E-ISSN 1744-8387, this journal has been pivotal in disseminating high-quality research from its inception in 2004 to its planned convergence in 2024. Its influential position is reflected in its 2023 rankings, placing it in the Q2 category for both Biochemistry and Molecular Biology, alongside respectable Scopus rankings that rank it 118th and 141st in its respective categories. Despite its non-open access structure, Expert Review of Proteomics provides researchers and professionals with a vital platform for critical reviews and insights into proteomic methodologies, thus contributing significantly to the global scientific community. By bridging theoretical research with practical applications, it serves as an essential resource for those dedicated to advancing their knowledge and expertise in this dynamic field.

Journal of Biochemistry

Your essential resource for biochemical advancements.
Publisher: OXFORD UNIV PRESSISSN: 0021-924XFrequency: 12 issues/year

Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.

Molecular Systems Biology

Unraveling the Mysteries of Molecular Interactions
Publisher: SPRINGERNATUREISSN: 1744-4292Frequency: 12 issues/year

Molecular Systems Biology, published by SpringerNature, is a premier open access journal that has been a cornerstone in advancing the fields of biological science since its inception in 2005. With its ISSN 1744-4292, this journal exemplifies high scholarly standards, boasting an impressive suite of impact factors, including Q1 rankings across various disciplines such as Agricultural and Biological Sciences, Biochemistry, Genetics and Molecular Biology, and more, highlighting its significant contribution to the scientific community. The journal offers robust access options to facilitate innovative research dissemination, reaching a global audience while maintaining a commitment to fostering collaboration and dialogue among researchers, professionals, and students. With a focus on integrating quantitative approaches to biological systems, Molecular Systems Biology plays a vital role in addressing complex biological questions, paving the way for groundbreaking discoveries and advancements in healthcare, environmental sustainability, and functional genomics.

All Life

Championing Collaboration in Biological Research
Publisher: TAYLOR & FRANCIS LTDISSN: 2689-5293Frequency: 1 issue/year

All Life is a distinguished academic journal published by TAYLOR & FRANCIS LTD, based in the United Kingdom, focusing on the interdisciplinary realms of agricultural and biological sciences, biochemistry, genetics, and neuroscience. With the ISSN 2689-5293 and E-ISSN 2689-5307, this open-access journal aims to disseminate high-quality research from 2020 to 2024, facilitating a wider reach and impact across various fields. Notably, it holds a Q3 ranking in both Agricultural and Biological Sciences, as well as Biochemistry, Genetics and Molecular Biology, and a Q4 ranking in Neuroscience, reflecting its growing presence in these disciplines. All Life aims to foster collaboration among researchers, professionals, and students, encouraging innovative approaches in understanding life sciences. By delivering timely insights and thought-provoking discussions, the journal plays a crucial role in advancing knowledge and promoting interdisciplinary dialogue in the evolving landscape of life sciences research.

Cell Chemical Biology

Pioneering Open Access Research for Tomorrow’s Innovations.
Publisher: CELL PRESSISSN: 2451-9456Frequency: 12 issues/year

Cell Chemical Biology, published by Cell Press, stands at the forefront of interdisciplinary research in the realms of biochemistry, molecular biology, and pharmacology. With a robust impact factor evident in its prestigious Q1 quartile rankings across multiple categories including Clinical Biochemistry and Drug Discovery for 2023, this journal serves as a critical platform for disseminating cutting-edge scientific discoveries. As an Open Access publication, it ensures that vital research is accessible to a wide audience, fostering collaborations and driving innovation in the life sciences. Based in the United States, and featuring publications from 2016 to 2024, Cell Chemical Biology invites researchers, professionals, and students alike to contribute to its mission of advancing knowledge through rigorous peer-reviewed articles that address both fundamental and applied aspects of chemical biology.